GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials.

Chuqing CaoShuting YangZhiguang Zhou

Published in: Endocrine (2019)

This meta-analysis did not suggest any increased risk of cancers associated with GLP-1RAs use in T2DM. The reduction in the risk of overall cancer associated with albiglutide needs to be examined further.

Keyphrases

systematic review
papillary thyroid
type diabetes
squamous cell
childhood cancer
cardiovascular disease
lymph node metastasis
glycemic control
randomized controlled trial
squamous cell carcinoma
meta analyses
young adults
adipose tissue
metabolic syndrome
insulin resistance